351 related articles for article (PubMed ID: 17418582)
1. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activity of substituted luotonin A derivatives.
Dallavalle S; Merlini L; Beretta GL; Tinelli S; Zunino F
Bioorg Med Chem Lett; 2004 Dec; 14(23):5757-61. PubMed ID: 15501036
[TBL] [Abstract][Full Text] [Related]
3. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
[TBL] [Abstract][Full Text] [Related]
4. Regioselective quinazolinone-directed ortho lithiation of quinazolinoylquinoline: practical synthesis of naturally occurring human DNA topoisomerase I poison luotonin a and luotonins B and E.
Mhaske SB; Argade NP
J Org Chem; 2004 Jun; 69(13):4563-6. PubMed ID: 15202923
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.
Cagir A; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
Bioorg Med Chem; 2004 Dec; 12(23):6287-99. PubMed ID: 15519171
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biochemical properties of E-ring modified luotonin A derivatives.
Cagir A; Jones SH; Eisenhauer BM; Gao R; Hecht SM
Bioorg Med Chem Lett; 2004 May; 14(9):2051-4. PubMed ID: 15080977
[TBL] [Abstract][Full Text] [Related]
7. D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.
Almansour AI; Kumar RS; Arumugam N; Bianchini G; Menéndez JC; Mohammad F; Dupadahalli K; Altaf M
Biomed Res Int; 2019; 2019():2514524. PubMed ID: 31815127
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
9. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
10. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
[TBL] [Abstract][Full Text] [Related]
11. Position-Selective Synthesis and Biological Evaluation of Four Isomeric A-Ring Amino Derivatives of the Alkaloid Luotonin A.
Ibric A; Eckerstorfer S; Eder M; Louko I; Tunjic L; Heffeter P; Schueffl HH; Marian B; Haider N
Molecules; 2019 Feb; 24(4):. PubMed ID: 30781470
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
[TBL] [Abstract][Full Text] [Related]
14. 5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicity.
Spicer JA; Finlay GJ; Baguley BC; Velea L; Graves DE; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):37-45. PubMed ID: 10363026
[TBL] [Abstract][Full Text] [Related]
15. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
Han S; Xiao Z; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Bridewell DJ; Finlay GJ; Baguley BC
Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884
[TBL] [Abstract][Full Text] [Related]
20. One-pot synthesis of luotonin A and its analogues.
Tseng MC; Chu YW; Tsai HP; Lin CM; Hwang J; Chu YH
Org Lett; 2011 Mar; 13(5):920-3. PubMed ID: 21268635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
